A director at Floridienne S.A. bought 30 shares at 605.000EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
                                                                                Alfen: Preview - kitchen sinking again? CM.com: New CFO appointed. Cofinimmo: Good results a touch better than forecasts, guidance reconfirmed, DEME Group: Wins strategic position in Brazil. D'Ieteren: State Farm TPA contract details emerge. Signify: 3Q25 results – guidance cut. Xior Student Housing: 5.4% LFL growth and full occupancy – operational trends solid.
                                                                                Xior reported EPRA EPS of €1.52 that came slightly below our €1.53 expectation (excl. IFRIC costs). However, Xior confirmed its flat EPRA EPS outlook for FY25 of 2.21 per share. The new rental season in Iberia and Poland starts mainly in 4th quarter. Xior NRI rose 7% yoy and like-for-like growth remained strong at 5.42%. LTV% continued below 50% at 49.75%. The cost of debt decreased slightly from 3.10% (FY24) to 3.06%. The asset disposal program has largely terminated and Xior gradually develops...
                                            UPDATE ON FIXED INCOME INVESTOR MEETINGS Press release Antwerp, Oct. 23, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO) (“CMB.TECH”) references the stock exchange release dated 20 October 2025 regarding fixed income investor meetings. Following engagement with potential investors, CMB.TECH has decided not to proceed with the issue of a senior unsecured bond. The indicative terms offered under the current market conditions were less favourable compared to the other funding sources available to the Company. For further informat...
                                                                                Floridienne is a holding with full private market exposure, ESG focus, and long-term family stewardship. Floridienne transformed over the past decade from a multi-asset to a de facto mono-holding. The main driver of this transformation is the superior performance of its crown jewel BioFirst, a global leader in biocontrol benefiting from the trend toward sustainability in agriculture. Floridienne's valuation and investment thesis depend on its continued success story. We reiterate our Accumulate ...
    
            Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.